Artificial Intelligence in Genomics Market worth $1,671 million by 2025

According to the new market research report Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research) - Global Forecasts to 2025, published by MarketsandMarkets™, the global AI in Genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025

Browse in-depth TOC on "Artificial Intelligence in Genomics Market"
141 – Tables
24 – Figures
154 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

Machine learning to dominate the AI in Genomics market in 2019

Based on technology, the Artificial Intelligence in Genomics Market is segmented into machine learning and other technologies. The machine learning segment dominated this market in 2019, as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug genomics applications. This is because machine learning can extract insights from data sets, accelerating genomic research.

Diagnostics segment accounted for the largest share of the AI in Genomics market, by end user, in 2019

Based on application, the Artificial Intelligence in Genomics Market is segmented into diagnostics, drug discovery & development, precision medicine, agriculture & animal research, and other applications. Diagnostics was the largest application segment in genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases and the decreasing cost of sequencing.

North America is the largest regional market for AI in Genomics in 2019

In 2019, North America accounted for the largest share of the AI in Genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.

Prominent players in the Artificial Intelligence in Genomics Market are IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK),Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (US)

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36649899

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Single use Bioreactors Market worth $8.8 billion by 2026

According to the new market research report Single use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to 2026, published by MarketsandMarkets™, the global Single-Use Bioreactors Market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750

Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.

Single-use bioreactor systems accounted for the largest share of single use bioreactors market

Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the market in 2020. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.

Stirred-tank SUBs accounted for the largest share of single-use bioreactors market

Based on type, the single-use bioreactors market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

The contract research organizations (CROs) and contract manufacturing organizations (CMOs) is the fastest-growing end user segment of the single-use bioreactors market

Based on end users, the single use bioreactors market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), and academic & research institutes. The contract research organizations (CROs) and contract manufacturing organizations (CMOs) segment is projected to register the highest CAGR in the single-use bioreactors market during the forecast period. The increasing outsourcing of R&D and manufacturing services by pharmaceutical and biopharmaceutical companies is expected to support the growth of the CROs & CMOs segment.

North America accounted for the largest share of the market

North America accounted for the largest share of the single-use bioreactors market, followed by Europe in 2020. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the single-use bioreactors market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750

The prominent players operating in the single use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Disposable Medical Device Sensors Market Leading Players and Business Trends

According to the new market research report Disposable Medical Device Sensors Market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period.

Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for home-based medical care devices, significant technological advancements in the last few years, and government support for R&D activities for these devices. The emerging markets in developing countries are also expected to provide growth opportunities for players in the disposable medical device sensors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1259

However, the vulnerability of connected medical devices in terms of data leakages, government regulations, and the long certification and approval cycles are major challenges faced by the market.

The disposable medical device sensors market is a competitive market, with few large as well as emerging players. The prominent players in this market are Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Medtronic (Ireland), Texas Instrument (US), Platinum Equity Advisors LLC (US), NXP Semiconductors (Netherlands), General Electric Company (US), TE Connectivity (Switzerland), STMicroelectronics (Switzerland), Honeywell International Inc. (US), Analog Devices, Inc. (US), Smiths Group Plc (UK), and Koninklijke Philips N.V. (Netherlands).

ABBOTT (US)

Abbott was ranked first in the disposable medical device sensors market in 2020. It is a global, diversified healthcare company dedicated to discovering, developing, manufacturing, and marketing pharmaceuticals, nutritional products for children and adults, and medical products such as devices, diagnostic tests, and instruments. Abbott provides continuous glucose and blood glucose monitoring systems under the FreeStyle brand. The company focuses on building country-specific portfolios made of high-quality products that meet the needs of people in emerging markets.

F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)

Roche held the second position in the disposable medical device sensors market in 2020. The company offers the industry’s most comprehensive in-vitro diagnostics solutions, covering clinical chemistry and immunoassays, molecular and digital diagnostics, point-of-care testing, patient self-testing, next-generation sequencing, laboratory automation and IT, and decision support. Roche serves customers spanning the entire healthcare spectrum—from hospitals, commercial laboratories, and research institutions to physicians and patients. Roche Diabetes Care aids people with diabetes and healthcare professionals through innovative Accu-Chek products and impactful solutions for convenient, efficient, and effective diabetes management. This includes blood glucose meters, lancing devices, insulin delivery systems, and digital solutions for data management, advice, coaching, and education.

Based on products, the medical device sensors market is segmented into biosensors, accelerometers, temperature sensors, image sensors, and other sensors. The biosensors segment accounted for the largest share in 2020.

Based on applications, the disposable medical device sensors market is segmented into patient monitoring, diagnostic testing, therapeutics, and imaging. The diagnostic testing segment accounted for the largest share in 2020. The large share of this application segment can primarily be attributed to the rising incidence of lifestyle diseases across the globe.

Based on type, disposable medical device sensors are segmented into strip sensors, wearable sensors, invasive sensors, and ingestible sensors. The strip sensors segment accounted for the largest share of the market in 2020.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1259

The medical device sensors market is divided into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America dominated the global market. The large share of the North American region is mainly attributed to the rising incidence of HAIs and chronic diseases in the region. Further, the availability of technologically advanced sensor-based disposable medical devices due to the presence of major players in the North American region also support the market growth.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

eHealth Market Leading Players and Business Trends

According to the new market research report eHealth Market is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period.

Factors such as the increased adoption of eHealth solutions, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the eHealth market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143

Players in the global eHealth industry include Cerner (US), McKesson (US), Philips Healthcare (Netherlands), GE Healthcare (US), and Allscripts (US). Other leading players in this market include athenahealth (US), Epic Systems (US), IBM (US), Optum (US), Siemens Healthineers (Germany), Medtronic (Ireland), and Cisco Systems (US).. These players are focusing on increasing their presence in high-growth markets through both organic as well as inorganic growth strategies, including service launches, expansions, collaborations, and partnerships.

GE Healthcare (US) held significant poistion in the global eHealth market in 2019. GE Healthcare is a leading provider of eHealth solutions. It has a strong and robust product and service portfolio of EHR and EMR solutions and services; PACS and VNA solutions; and health information exchange solutions. The company concentrates on R&D activities. It focuses on developing new and improved products and services. GE Healthcare has launched 25 new products, services, and digital solutions in the market. Such initiatives undertaken by the company provide it a competitive edge over other players operating in the eHealth market and help it maintain its foothold in the market.

Cerner (US) also accounted for considerable market share in eHealth market in 2019. Cerner has a robust eHealth solutions portfolio tailored for medium- and large-sized healthcare enterprises to help them with advanced software and services, designed specifically to cater to their requirements. The key strength of the company is its wide geographic presence and extensive distribution network across leading markets. Cerner has a strong global presence. Approximately 88.0% of its revenue is generated from North America. However, the company is focusing on expanding its operations in non-US markets, along with entering new markets through business expansions and the adoption of inorganic growth strategies.

Based on end user, the eHealth market has been segmented into healthcare providers, healthcare payers, healthcare consumers, pharmacies and other end-users of these, healthcare providers segment accounted for the largest share of the eHealth solutions market in 2019. Healthcare providers include hospitals, ASCs and home healthcare agencies. High segmental market share can is attributable to the increasing hospital and out-patient admissions.

Based on eHealth solutions, EHR/EMR Solutions, Medical Apps, Picture Archiving and Communication, Systems & Vendor Neutral Archive, Chronic Care Management Apps, PHR & Patient Portals, Health Information Exchange Solutions, Telehealth Solutions, Pharmacy Information Systems, Laboratory Information Systems, Clinical Decision Support Systems, E-Prescribing Solutions, Radiology Information Systems, Cardiovascular Information Systems and Other Specialty Information Systems The market for EHR/EMR segment is expected to grow significantly in the forthcoming years.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=11513143

Geographically, the North American eHealth Market accounted for the largest share of the eHealth solutions market in 2019 due to the presence of a well-established base of eHealth companies, high investments in the several healthcare IT, and increasing R&D expenditure. The Asia Pacific market is expected to register the highest growth during the forecast period due to increasing healthcare expenditures and improving regulatory scenario.
Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Spirometer Market Top Players and Business Intelligence

According to the new market research report Spirometer Market is projected to reach USD 1,285 million by 2025 from USD 799 million in 2020, at a CAGR of 11.1%.

Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition. On the other hand, dependence on patient and other human interventions for data will hinder the growth of this market and will remain a challenge.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659

The spirometer market isconsolidated in nature. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), ndd Medical Technologies (Switzerland), Vitalograph (UK), and Midmark Corporation (US).

Hill-Rom is the largest player in the spirometer market. The company focuses on the development of devices, consumables, accessories, and software required to perform spirometer tests. These products are sold under the brand Welch Allyn. The company also invests a significant amount on research and development activities.

Vyaire Medical is a pioneer in the spirometer market. As a result, it has a strong foothold in the spirometer devices market. The company was formed by a partnership between BD and Apax Fund Partners, when BD divested its respiratory care business. Apax Fund Partners took over the complete holdings of Vyaire Medical in 2019. Vyaire Medical has a global distribution network and has a good brand reputation among end users.

Based on product, the spirometer market is segmented into devices, consumables & accessories, and software. This segment is expected to witness the highest growth rate during the forecast period.

Based on mechanism, the spirometer market is segmented into flow-sensing spirometer and peak flow meters. The flow- sensing segment accounted for the highest share in 2019.

Request For Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18015659

The global spirometer market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The North American market is expected to account for the highest market share in 2019. The large share of this market segment can be attributed to the increasing incidence of chronic respiratory diseases and the rising adoption of technologically advanced devices in the region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

 

X-Ray Detectors Market Insights on Scope and Growing Demands 2024

According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.

Factors such as declining prices and benefits offered by digital detectors, growing public and private investments in Digital Imaging technologies and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984

Based on type, the market is segmented into flat-panel detectors (FPDs), computed radiography (CR) detectors, charge-coupled device (CCD) detectors, and line-scan detectors. In 2019, the flat-panel detectors segment is expected to account for the largest share of the X-ray detectors market. The growth in this market is mainly driven by the advantages offered by FPD-based portable digital systems (such as high-quality images, faster scanning, increased patient throughput, and multiple storage options), their decreasing prices, and the growing demand for retrofit FPD-based digital X-ray systems.

By application, the market is segmented into medical, dental, security, veterinary, and industrial applications. The medical applications segment is expected to grow at the highest rate during the forecast period. The growth in this segment can primarily be attributed to the advancements in medical technology, rising geriatric population, and the increasing number of orthopedic and cardiovascular procedures.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Recent Developments

> In May 2017, Varex Imaging Corporation acquired PerkinElmer's medical imaging business to expand its digital flat-panel detectors business.
> In December 2016, Canon Inc. acquired Toshiba Medical Systems Corporation to enhance its position in the healthcare industry.

The X-ray detectors market is highly competitive with several big and small players. Prominent players in this market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Hamamatsu Photonics K.K. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Analogic Corporation (US), Rayence (South Korea), and DRTECH (South Korea).

Recent Developments

> In May 2017, Varex Imaging Corporation acquired PerkinElmer's medical imaging business to expand its digital flat-panel detectors business.
> In December 2016, Canon Inc. acquired Toshiba Medical Systems Corporation to enhance its position in the healthcare industry.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=7004984

In 2019, North America is expected to account for the largest share of the X-ray detectors market, followed by Europe, Asia, and the RoW. The large share of North America is attributed to factors such as technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases in the region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Coronary Stents Market Insights on Scope and Growing Demands 2021

According to the research report the Coronary Stents Market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021.

Major factors driving the growth of this market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=77411272

Technological advancements, increasing demand for minimally invasive procedures and rapid growth in geriatric population are the major drivers for the market.

The coronary stents market is witnessing a new phase of technological developments, with the launch of fully dissolving stents. In July 2016, Abbott (US) received US FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the only fully dissolving stent approved for the treatment of CAD. Moreover, researchers have also developed dual-therapy stents and bioengineered stents for the treatment of CAD. Innovations in stenting technology, in terms of material, construction, and coatings play a major role in increasing the effectiveness of stents and expanding their application areas. Moreover, launching innovative products in the market helps companies gain a competitive advantage and drive the uptake of their products.

Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. The drug-eluting stents segment is expected to account for the largest share of the coronary stents market in 2016. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications. Based on mode of delivery, the Coronary Stents Market is segmented into balloon-expandable stents and self-expanding stents. The balloon expandable stents segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing research activities to improve this technology, high utilization of these stents, and growing regulatory approvals for balloon-expandable stents.

Based on region, the Coronary Stent Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. Asia is poised to be the fastest-growing region during the forecast period. Factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region are expected to drive market growth in Asia. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77411272

The Coronary Stents Market is a highly fragmented market, with several big and emerging players. Key market players include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), B. Braun Melsungen AG (Germany), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com